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The Acute Autonomic Stress Response and Amniotic Fluid Glucocorticoids in
Second-Trimester Pregnant Women
PEARL LA MARCA-GHAEMMAGHAMI, PHD, SARA M. DAINESE, PHD, ROBERTO LA MARCA, PHD, ROLAND ZIMMERMANN, MD,
AND ULRIKE EHLERT, PHD
Objective: The maternal autonomic nervous system (ANS) has received little attention in the investigation of biological mechanisms
linking prenatal stress to fetal cortisol (F) excess. In vitro, norepinephrine and epinephrine inhibit placental 11A-hydroxysteroid dehy-
drogenase type 2 (11A-HSD2), which protects the fetus from F overexposure by inactivating it to cortisone (E). Here, we investigated
the acute ANS stress response to an amniocentesis and its association with amniotic fluid F, E, and E/(E + F) as a marker of fetoplacental
11A-HSD2 activity. Methods: An aliquot of amniotic fluid was obtained from 34 healthy, second-trimester pregnant women under-
going amniocentesis. Repeated assessment of mood states served to examine the psychological stress response to amniocentesis. Saliva
samples were collected to measure stress-induced changes in salivary >-amylase concentrations in response to amniocentesis. Cardiac
parameters were measured continuously. Results: Undergoing amniocentesis induced significant psychological and autonomic alter-
ations. Low-frequency (LF)/high-frequency (HF) baseline, suggested to reflect sympathovagal balance, was negatively correlated with
amniotic E/(E + F) (r=j0.53, p = .002) and positively with F (r = 0.62, p G .001). In contrast, a stronger acute LF/HF response was
positively associated with E/(E + F) (r = 0.44, p = .012) and negatively with F (r=j0.40, p = .025).Conclusions: These findings suggest
that the maternal ANS is involved in the regulation of the fetoplacental barrier to stress. Allostatic processes may have been initiated
to counterbalance acute stress effects. In contrast, higher LF/HF baseline values, possibly indicative of chronic stress exposure, may have
inhibited 11A-HSD2 activity in the fetoplacental unit. These results parallel animal findings of up-regulated placental 11A-HSD2 in
response to acute stress but impairment under chronic stress.Key words: prenatal stress, amniotic fluid, cortisone/cortisol ratio, 11A-HSD2,
autonomic nervous system, LF/HF HRV.
11A-HSD1 = 11A-hydroxysteroid dehydrogenase type 1; 11A-HSD2
= 11A-hydroxysteroid dehydrogenase type 2; ANOVA = analysis of
variance; ANS = autonomic nervous system; AUCi = area under the
curve with respect to increase; E = cortisone; EPI = epinephrine; F =
cortisol; HF = high-frequency component of heart rate variability;
HPA = hypothalamic-pituitary-adrenal; HR = heart rate; HRV = heart
rate variability; LF = low-frequency component of heart rate
variability; M = mean; Mdn = median; MMSQ = Multidimensional
Mood State Questionnaire; NE = norepinephrine; sAA = salivary >-
amylase; SD = standard deviation; SEM = standard error of the mean;
UV = ultraviolet.
INTRODUCTION
Abody of evidence from animal and increasingly from humanstudies suggests that excessive psychological stress during
pregnancy can adversely affect fetal development in utero and
maternal and child well-being after birth (1,2). For example, in-
creased prenatal maternal stress and anxiety have been associated
with an altered activity of the hypothalamic-pituitary-adrenal
(HPA) axis in neonates (3) and adolescents (4), with impaired
cognitive development in infants (5), increased emotional and
behavioral problems (6), and symptoms of attention-deficit hy-
peractivity disorder in children (7), and with shortened telomere
length in young adults (8). These and other findings have led re-
searchers to propose that similar to malnutrition during pregnancy,
maternal prenatal stress may exert programming effects on the
developing fetus and thereby increase the individual’s suscepti-
bility to disease in later life (9).
To elucidate the underlying biological mechanisms by which
prenatal maternal stress may reach the fetus, research has largely
focused on the maternal and fetal HPA axes and the detrimen-
tal effects of fetal glucocorticoid excess. Glucocorticoid over-
exposure seems to impair the activity of the placental enzyme
11A-hydroxysteroid dehydrogenase type 2 (11A-HSD2), which
converts hormonally active cortisol (F) into inactive cortisone
(E) to shield the fetus from maternal F excess (10). Because of
11A-HSD2, the F levels within the fetal system remain several fold
lower than the F levels within the maternal system (e.g., ref. (11)).
In rats, acute maternal stress induces an immediate up-regulation
of placental 11A-HSD2 activity, but after maternal chronic stress
exposure, this up-regulation is impaired resulting in F excess to
the fetus (12,13). A parallel process has been proposed to exist in
humans because, from 5 weeks of gestation onward, 11A-HSD2
is also present in the human placental syncytiotrophoblast, the
site of maternal-fetal exchange (14). Support for this hypothesis
comes from a recent study revealing a negative association be-
tween anxiety in pregnant women and 11A-HSD2 activity and
messenger RNA (mRNA) expression in placental samples ob-
tained directly after birth (15).
Investigating placental 11A-HSD2 activity in response to
acute stress during ongoing human pregnancy poses ethical and
medical challenges. This also applies to studies aiming at ex-
amining 11A-HSD2 activity in vivo in other human tissues
where the enzyme is highly expressed, such as the kidney. To
do so, researchers have relied on the ratio between urinary free
F and E as a surrogate marker for renal 11A-HSD2 activity
(16,17). This ratio has been found to correlate with the mRNA
expression of 11A-HSD2 in kidney tissues obtained from pa-
tients undergoing kidney biopsies (18). Hundertmark et al. (19)
used the ratio between amniotic fluid F and E obtained at 21 to
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38 weeks of gestation as a marker of 11A-HSD2 activity in the
human fetal kidney because during this period of gestation,
amniotic fluid is increasingly produced by fetal urination. Before
this periodVthat is between 10 and 20 weeks of gestationVthe
composition of amniotic fluid largely resembles the composition
fetal plasma, because the extracellular fluid can diffuse through
the not-yet-keratinized fetal skin into the amniotic fluid (20). In
the fetal membranes, 11A-HSD2 has been detected from 8 weeks
of gestation onward (21). However, the capacity of placental 11A-
HSD2 to metabolize F is assumed to exceed the capacity of fetal
11A-HSD2 to metabolize F (22). On this basis, our workgroup
previously examined F, E, and the E/(E + F) ratio in amniotic fluid
samples obtained from second-trimester amniocenteses as a
marker for 11A-HSD2 activity in the fetoplacental unit (23). Our
results showed that the maternal salivary F response was posi-
tively and significantly related to amniotic fluid E and at bor-
derline significance to amniotic fluid E/(E + F). This finding
indicates that the placental barrier to F functions in response to
acute stress during ongoing human pregnancy, as it does in
pregnant rats (23).
In comparison with the HPA axis, little attention has been
paid to date to the potentially important role of the autonomic
nervous system (ANS), which, like the HPA axis, is activated
by stress. In vitro, placental 11A-HSD2 is inhibited by nor-
epinephrine (NE) and epinephrine (EPI) (24), highlighting the
importance of also investigating this stress-sensitive system
when exploring the underlying biological pathways of prenatal
stress (9,15,25). To what extent the maternal ANS response
may be associated with amniotic fluid F, E, and E/(E + F) is
unknown. Plasma NE and EPI levels in nonpregnant partici-
pants have been associated with other ANS markers involved in
the stress response, such as salivary >-amylase (sAA) and heart
rate (HR) variability (HRV) (26,27), although findings remain
inconsistent (28). The advantage of measuring the activity of
these ANS markers in response to stress in pregnant women is
that they can be investigated easily and noninvasively.
In the current study, we a) examined the stress response of
different ANS markers (i.e., sAA, HR, and HRV) in pregnant
women before, during, and after second-trimester amniocente-
sis compared with a control condition and b) explored whether
these stress markers were associated with amniotic fluid F, E, and
the E/(E + F) ratio as a marker of 11A-HSD2 activity in the
fetoplacental unit (10,22,29).
METHODS
Study Participants
Thirty-four healthy pregnant women with a singleton intrauterine preg-
nancy were examined while undergoing second-trimester amniocentesis for
karyotyping. Participants were recruited at different Swiss hospitals after regis-
tering for amniocentesis. In Switzerland, testing for fetal chromosomal anomalies
is routinely recommended to pregnant women 34 years and older. Also, because
in Switzerland the mean age of women at maternity is 31.4 years (30), many
pregnantwomenundergo prenatal genetic testing. In the present study, 20 pregnant
women (58.8%) mentioned advanced age as a reason for amniocentesis (31).
Other reasons given included a positive result in the first-trimester screening
test (26.5%; n= 9), chromosomal anomalies in a previous pregnancy (2.9%; n = 1),
and simply wanting to make sure that all is well with the fetus even without
apparent evidence for an increased risk (11.8%; n = 4) (31).
None of the participants or their fetuses were affected by medical compli-
cations, and all participants had a normal amniocentesis result. Pregnancies via
artificial insemination, current mental disorders, medication, smoking, or obe-
sity were defined as exclusion criteria. Liquorice consumption was screened for
as well, because its main ingredient, glycyrrhetinic acid, is a well-known in-
hibitor of 11A-HSD2 activity (32). None of the participants consumed liquorice
during pregnancy. The study was carried out in accordance with the tenets of
the Declaration of Helsinki, and ethical approvals were obtained by the cantonal
ethics committees of Zurich, Schaffhausen, and Lucerne. All participants gave
informed written consent.
Study Design and Procedure
The study at hand is part of a larger research project on the psychobiology
of stress during human pregnancy (23,31). The study design is presented in
Figure 1. Because of hospital logistics and proceedings, all amniocenteses
were conducted during morning hours. Participants arrived approximately
50 minutes before the amniocentesis, filled in study administrative question-
naires, and were subsequently asked to put on an ambulatory electrocardio-
graphic device before being seated in a semirecumbent chair. Cardiac activity
was continuously measured, and repeated saliva samples and psychological
measurements were obtained. Gestational age was determined by fetal ultrasound
biometry before the amniocentesis. After the amniocentesis, participants were
still monitored for 60 minutes to capture the stress recovery period. We invited
the pregnant women to participate in a control condition after they had received
the notification of a normal amniocentesis test results (mean [M; standard devia-
tion {SD} = 2.74 [1.00] weeks after the amniocentesis). All 34 pregnant women
participated. The procedure of the control condition was identical to the amnio-
centesis condition, except that no amniocentesis took place. It was scheduled at
the same time as the amniocentesis condition to control for circadian fluctuations.
Outcome Measures
Psychological Measures
Maternal mood was assessed before and after the amniocentesis at j40,
j10, and +20 minutes (see Fig. 1) and at equivalent times during the control
condition using the validated 24-item German version of the Multidimensional
Mood State Questionnaire (MMSQ) (33). The MMSQ is composed of three
subscales: ‘‘good-bad mood’’ (Cronbach > = .91-.94), ‘‘calmness-nervousness’’
Figure 1. Study design and procedure. MMSQ = Multidimensional Mood State Questionnaire.
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(Cronbach > = .92-.96), and ‘‘wakefulness-tiredness’’ (Cronbach > = .86-.91).
Participants are asked to rate to what extent they, for example, feel ‘‘content’’,
‘‘restless, or ‘‘worn-out’’ on a 5-point Likert scale (1= definitely not, 5 = extremely).
Higher scores indicate good mood, calmness, and wakefulness.
Biochemical Measures
Salivary >-Amylase
Saliva samples were collected with Salivettes (Sarstedt, Sevelen, Switzerland)
atj20,j10,j1, +1, +10, +20, +30, +45, and +60 minutes. The saliva samples
were stored at j20-C until biochemical analysis. After thawing, sAA activity
was analyzed with the automatic analyser Cobas Mira and assay kits from Roche
(27) with intra-assay and interassay coefficients of variation lower than 8%.
Because of insufficient saliva, a total of eight missing values from seven diffe-
rent participants were replaced, following Jo¨nsson et al. (34), by calculating the
slope between the missing and the subsequent value across all participants and
multiplying it by the value of the individual participant preceding the missing one.
Marker of 11A-HSD2 Activity
Amniotic fluid parameters: a surplus of 2 ml amniotic fluid was obtained
and stored at j80-C. F and E were analyzed using reversed-phase high-
performance liquid chromatography with UV detector. The intra-assay and inter-
assay coefficients of variation are shown to be lower than 5% for both F and E
in urine and plasma. Intra-assay coefficients of variation for amniotic fluid F and E
have been found to be lower than 3% (35).
11A-HSD2 activity in the fetoplacental unit was assessed in percentage
using the subsequent formula: E/(E + F) * 100 (cf. Refs. (10,22,29)). In the
following, this variable is reported as E/(E + F) for brevity’s sake.
Electrophysiological Measures
Cardiac activity was measured using the LifeShirt system 200 (Vivometrics,
Ventura, CA) (36). Five-minute intervals of raw data were edited manually and
corrected for ectopic beats and arrhythmias by applying linear interpolations.
These selected intervals began at j32.5, j17.5, j5, +12.5, +32.5, and +47.5
minutes. After applying fast Fourier transformation, the corrected interbeat in-
tervals were analyzed for HR and frequency domain measures of HRV, that
is, high-frequency (HF; 0.15-0.4 Hz, mirroring parasympathetic modulation of
HR and cardiac vagal activity) and low-frequency (LF; 0.04-0.15 Hz, mirroring
both sympathetic and parasympathetic modulation). The ratio between the
two (LF/HF) is thought to reflect sympathovagal balance, but this concept has
also provoked controversy (37,38). Prior studies have observed a decreased HF
and increased LF/HF ratio in response to psychosocial stress in both second-
trimester pregnant and nonpregnant women alike, whereas no significant
changes were found for LF (39), indicating a predominant vagal response to acute
psychological stress.
Data Analyses
Data were tested for normal distribution, whereupon sAA, HF, LF, LF/HF,
and amniotic fluid E underwent natural log transformation (ln) due to skewness.
Then, to ensure the comparability of variables when conducting analyses to
explore potential associations between maternal ANS and amniotic fluid pa-
rameters, previously untransformed variables (i.e., HR and amniotic fluid F)
underwent natural log transformation as well. This procedure is in line with
Field (40). Both maternal HR and amniotic fluid F remained normally dis-
tributed after transformation. The E/(E + F) ratio was calculated with the
untransformed E and F values, as it constitutes a specific formula in percentage
and was normally distributed.
Two-way repeated-measures analyses of variance (ANOVAs) were computed
to identify possible interaction effects between the amniocentesis and control
condition. Wherever the assumption of sphericity was violated, results underwent
Greenhouse-Geisser correction. Values for the area under the curve with respect
to increase (AUCi) were computed using the trapezoid formula (41) while addi-
tionally controlling for participants’ individual baseline value (last measure-
ment point of the study protocol). Comparisons between the two conditions were
analyzed with paired Student’s t tests. For post hoc testing, ANOVAs were
conducted for each condition separately and Bonferroni tests were computed
to examine possible differences between the individual time points.
With regard to psychological measures, nonnormal distributions were found
for the good-bad mood and calmness-nervousness subscales of the MMSQ.
Therefore, nonparametric tests were used for these two scales. Possible differ-
ences between the conditions were examined with the Wilcoxon signed rank
test. Effects of time were investigated using Friedman ANOVA.
Potential associations between maternal psychological, ANS, and amniotic
fluid parameters were explored using bivariate and partial correlations. Control
variables were determined before the correlation analyses by conducting bivari-
ate correlations (Pearson and Kendall T correlations) between maternal charac-
teristics and untransformed maternal physiological markers. These control
variables included gestational age (associatedwith baseline HR: r = 0.48, p = .011;
baseline HF: T = j0.41, p = .001; baseline LF/HF: T = 0.27, p = .022; sAA
reactivity: T = 0.24, p = .055; and amniotic fluid F: r = 0.36, p = .044) andmaternal
body mass index (associated with HR reactivity: r = j0.34, p = .047).
All analyses were two tailed. The level of significance was set at p G .05.
RESULTS
Sample Characteristics
Sociodemographic and pregnancy-related characteristics of
the participants are presented in Table 1.
Effects of the Amniocentesis
Maternal Psychological Stress Response
Results for the good-bad mood subscale of the MMSQ indi-
cated that mood was significantly worse atj40 andj10 minutes
of the amniocentesis compared with the control condition
(Wilcoxon signed rank test at j40 minutes: amniocentesis: me-
dian [Mdn] = 34.50; control condition: Mdn = 38.00; z = j2.72,
N-Ties = 29, p= .005, r=j0.33;Wilcoxon signed rank test atj10
TABLE 1. Sociodemographic and Pregnancy-Related Characteristics
(n = 34)
Maternal age, M (SD) [range], y 37.38 (4.02) [27.00Y45.00]
Marital status, % (n)
Single 32.4 (11)
Married 58.8 (20)
Divorced 8.8 (3)
Living with partner in
same household, % (n)
82.4 (28)
Ethnicity, % (n)
European 82.4 (28)
Asian 14.7 (5)
African Caribbean 2.9 (1)
Education, % (n)
G10 y 8.8 (3)
10Y13 y 41.2 (14)
913 y 50 (17)
Working time, M (SD) [range], % 69.71 (40.04) [0Y100]
Annual income (Swiss Francs), % (n)
G40,000 32.4 (11)
40,000Y60,000 8.8 (3)
960,000 52.9 (18)
BMI at amniocentesis,
M (SD) [range], kg/m2
22.66 (2.14) [19.60Y27.30]
Gestational age at amniocentesis,
M (SD) [range]
15.96 (0.71) [15.00Y17.86]
Nulliparous, % (n) 64.7 (22)
M = mean; SD = standard deviation; BMI = body mass index.
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minutes: amniocentesis: Mdn = 34.00; control condition: Mdn =
38.00; z =j4.40, N-Ties = 29, p G .001, r =j0.53) but not at +
20 minutes (Wilcoxon signed rank test at +20 minutes: am-
niocentesis: Mdn = 36.00; control condition: Mdn = 37.50; p =
.055; Fig. 2A).
Mood varied across time during the amniocentesis at mar-
ginal significance (Friedman ANOVA: W2(2) = 5.41, p = .066),
but not during the control condition (W2(2) = 3.35, p = .19).
Results for the calmness-nervousness subscale of the MMSQ
showed significantly decreased calmness scores at all times points
during the amniocentesis compared with the control condition
(Wilcoxon signed rank test atj40minutes: amniocentesis:Mdn =
38.29; control condition: Mdn = 35.00; z = j4.31, N-Ties = 32,
p G .001, r =j0.52; Wilcoxon signed rank test atj10 minutes:
amniocentesis: Mdn = 29.00; control condition: Mdn = 34.50;
z =j4.19, N-Ties = 29, p G .001, r =j0.50; Wilcoxon signed
rank test at +20 minutes: amniocentesis: Mdn = 33.00; control
condition: Mdn = 35.00; z =j3.50, N-Ties = 29, p G .001, r =
j0.42; Fig. 2B)
Calmness-nervousness varied significantly across time dur-
ing the amniocentesis condition (Friedman ANOVA: W2(2) =
9.29, p = .009), but not during the control condition (W2(2) =
3.41, p = .18).
The two-way repeated-measures ANOVA for the wakefulness-
tiredness scale revealed no significant differences between the
conditions (F(1,32) = 1.31, p = .26). However, significant changes
across time were apparent (F(2,64) = 3.45, p = .038, G2 = 0.10).
The interaction effect failed to reach significance (interaction
condition by time: F(2,64) = 0.01, p = .99), suggesting that
wakefulness decreased across time in both conditions (Fig. 2C).
Maternal Salivary >-Amylase Response
The amniocentesis led to a significant increase in sAA over
time compared with the control condition (interaction condi-
tion by time: F(5.05,156.63) = 6.80, p G .001, G2 = 0.18; see
Fig. 3A). The AUCi of the amniocentesis condition (M = 23.54,
standard error of the mean [SEM] = 7.46) was significantly
larger compared with the control condition (M =j6.55, SEM =
6.01, t(31) = 3.02, p = .005, r = 0.48). Post hoc ANOVAs
revealed a significant effect of time across the amniocentesis
(F(5.06,161.86) = 7.68, p G .001, G2 = 0.19) but also across the
control condition (F(4.33,138.59) = 3.15, p = .014, G2 = 0.09).
The Bonferroni post hoc test revealed an sAA increase during
the control condition from j1 to +45 minutes (p = .005).
Maternal Cardiac Response
HR increased significantly during the amniocentesis com-
pared with the control condition (interaction condition by time
(F(3.46,110.81) = 13.37, p G .001, G2 = 0.30; see Fig. 3B). This
finding was confirmed by differences in the AUCi values be-
tween the conditions (amniocentesis condition: M = 474.00,
SEM = 51.39; control condition: M = 285.69, SEM = 78.52,
t(32) = 2.20, p = .035, r = 0.48). Post hoc ANOVAs yielded a
significant time effect for the amniocentesis (F(3.41,119.25) =
37.56, p G .001, G2 = 0.52) but also for the control condition
(F(3.01,96.23) = 4.72, p = .004, G2 = 0.13) because of a sig-
nificant decrease in HR during the control condition from j30
to +50 minutes (p = .002).
HF increased significantly during the amniocentesis com-
pared with the control condition (interaction condition by time
(F(5,160) = 3.87, p = .002, G2 = 0.11; see Fig. 3C). This result
was further substantiated by differences in the AUCi values
(amniocentesis: M = j10.20, SEM = 6.45; control condition:
M =j34.11, SEM = 6.25, t(32) = 2.83, p = .014, r = 0.45). Post
Figure 2. Psychological stress response of second-trimester pregnant women
across time during the amniocentesis and control condition measured with the
‘‘good-bad mood’’ (median; A), ‘‘calmness-nervousness’’ (median; B), and
‘‘wakefulness-tiredness’’ (mean [standard error of the mean]; C) subscales of
the MMSQ. Higher scores indicate increased good mood, calmness, wake-
fulness. ** p G .01, *** p G .001. MMSQ = Multidimensional Mood State
Questionnaire.
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hoc ANOVAs showed significant time effects for both condi-
tions (amniocentesis: F(3.51,119.31) = 9.10, p G .001, G2 =
0.21; control condition: F(3.78,117.29) = 6.57, p G .001, G2 =
0.18). Bonferroni post hoc tests revealed a significant increase
from j30 to +50 minutes during the control condition (p =
.001), as well as from j5 to +50 minutes (p G .001).
LF findings revealed neither a significant interaction effect
(p = .15) nor a significant difference between the AUCi values
(p = .59; Fig. 3D). However, a significant effect of condition
was apparent (F(1,32) = 15.92, p G .001, G2 = 0.33), indicating
that LF values were overall increased during the amniocentesis
compared with the control condition.
LF/HF decreased significantly during the amniocentesis
compared with the control condition (F(5,160) = 5.18, p G .001,
G2 = 0.14; see Fig. 3E). There was no significant difference
between the two AUCi values (p = .23). Post hoc ANOVAs
revealed a significant time effect in both conditions (amnio-
centesis: F(3.97,138.91) = 6.01, p G .001, G2 = 0.15; control
condition: (F(5,160) = 3.19, p = .009, G2 = 0.09) because of
a marginally significant decrease from +30 to +50 minutes (p =
.055) in the control condition.
Association Between the Maternal Psychological, ANS,
and Amniotic Fluid Variables
Wakefulness was positively associated with HR baseline
levels (r = 0.37, p = .032). Aside from this result, psychological
stress variables were unrelated to the maternal ANS and am-
niotic fluid variables (Supplemental Digital Content 1, http://
links.lww.com/CONT/A135).
Association Between Maternal ANS and Amniotic Fluid
Parameters
Association Between Maternal ANS Baseline Levels and
Amniotic Fluid F, E, E/(E + F)
A negative association was found between the LF baseline
and amniotic fluid E/(E + F) (r = j0.36, p = .042), and a
Figure 3. Stress response (mean and standard error of the mean) of salivary >-amylase (A), heart rate (B), high-frequency power (C), low-frequency power (D), and
the LF/HF ratio (E) during the amniocentesis condition compared with the control condition. * p G .05, ** p G .01, *** p G .001. HF = high-frequency component of
heart rate variability; LF = low-frequency component of heart rate variability.
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positive association was revealed between LF baseline and
amniotic fluid F (r = 0.40, p = .026). Moreover, the LF/HF
baseline was negatively correlated with amniotic fluid E/(E + F)
(r =j0.53, p = .002; see Fig. 4A) and positively amniotic fluid
F (r = 0.62, p G .001). No significant associations were found
between sAA, HR, and HF baseline values and any of the
amniotic fluid parameters (Supplemental Digital Content 2,
http://links.lww.com/CONT/A136).
The ANS Stress Response and Amniotic Fluid F, E, and
E/(E + F)
A trend toward significance was apparent for a positive re-
lationship between the sAA AUCi and amniotic fluid E/(E + F)
(r = 0.36, p = .055) and for a negative association between HF
and amniotic fluid E/(E + F) (r =j0.33, p = .062). No significant
associations were found between LF and amniotic fluid E or E/
(E + F), but a negative relationship was apparent for amniotic
fluid F (r = j0.37, p = .039). The LF/HF AUCi was positively
related to amniotic fluid E/(E + F) (r = 0.44, p = .012; see Fig. 4B)
and negatively to amniotic fluid F (r = j0.40, p = .025) (Sup-
plemental Digital Content 3, http://links.lww.com/CONT/A137).
DISCUSSION
To the best of our knowledge, this is the first study to in-
vestigate the association between the maternal ANS stress re-
sponse and amniotic fluid parameters during human pregnancy.
The amniocentesis provoked a significant anticipatory psycho-
biological stress response in second-trimester pregnant women
with a decrease in mood and increases in nervousness, sAA, and
HR. HF was decreased before the amniocentesis and started to
rise again, whereas the opposite was true for LF/HF. No signifi-
cant stress-induced LF changeswere revealed, although LF levels
were overall significantly higher during the amniocentesis com-
pared with the control condition. The maternal psychological re-
sponse to the amniocentesis was largely unassociated with the
maternal ANS and amniotic fluid parameters, except that maternal
wakefulness correlated positively with maternal HR baseline
levels. Regarding the association between the maternal ANS re-
sponse and amniotic fluid parameters, results showed that LFand
LF/HF baseline values were negatively related to amniotic fluid
E/(E + F). The E/(E + F) ratio served as a marker of 11A-HSD2
activity in the fetoplacental unit. Also, LF and LF/HF baseline
levels were positively associated with amniotic fluid F. As for the
acute stress response, LF/HF was positively related to amniotic
fluid E/(E +F) and bothLFandLF/HFwere negatively associated
with amniotic fluid F. Furthermore, correlations at borderline
significance were found between the acute sAA response and
amniotic fluid E/(E + F) (positive association) and between the
acute HF response and amniotic fluid E/(E + F) (negative
association).
Compared with the HPA axis, little attention has been paid
so far to the role of the maternal ANS in the research of prenatal
stress. Especially the investigation of sAA and HRV in response
to acute psychological stress during pregnancy is limited
(39,42,43). Salivary glands are innervated by both branches of
the ANS, and stress-induced sAA changes are thought to reflect
sympathetic activity (44), yet findings remain uncertain to
whether parasympathetic modulation may be involved as well
(28). Our results may, therefore, indicate increased sympathetic
activity during the amniocentesis, but further research is needed.
These findings parallel previous results from our workgroup on
nonpregnant healthy participants (27,45) and are in line with our
prior study on sAA reactivity during pregnancy revealing an in-
crease in second- and third-trimester pregnant women confronted
with an acute laboratory-based psychosocial stressor (42).
Cardiac autonomic activity seemed to exhibit an anticipatory
stress response, as the increased HR and LF/HF levels before
the amniocentesis suggest. Likewise, HF (i.e., vagal activity)
was decreased 20 minutes before the amniocentesis and began
to rise again. This poststress vagal rebound (46) reached sig-
nificance 15 minutes after the amniocentesis before returning to
levels comparable with the control condition. This suggests that
sympathetic activity may have predominated already before the
amniocentesis.
In line with previous results (39), we found no significant
LF changes over time, although levels were overall significantly
higher during the amniocentesis condition. Possibly, sympathetic
tonewas increased during the entire amniocentesis condition, yet
the validity of this interpretation remains uncertain, because LF is
influenced by both vagal and sympathetic activity (37).
Figure 4. Bivariate correlations between the baseline levels of the ln transformed LF/HF ratio and the amniotic fluid E/(E + F) ratio in % (A) and between the AUCi
(stress response) of the ln transformed LF/HF ratio and the amniotic fluid E/(E + F) ratio in % (B). HF = high-frequency component of heart rate variability; LF =
low-frequency component of heart rate variability; E = cortisone; F = cortisol; AUCi = area under the curve with respect to increase.
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Surprisingly, sAA and HF increased significantly during the
control condition while HR and LF/HF declined. HRV in-
creases (i.e., respiratory sinus arrhythmia) during a control
condition have been reported before (47) and may be a result of
increased relaxation. Relaxation has been associated with in-
creased HRV and decreased HR in third-trimester pregnant
women (48). Also, increased sAA concentrations during relax-
ation have been found in nonpregnant participants (49) because
sAA secretion is influenced by both sympathetic and parasym-
pathetic activities (28). The women in our sample might likewise
have been experiencing an increase in relaxation during the
control condition and, therefore, an increase in parasympathetic
activation. Our finding of a decrease in wakefulness across time
in the control condition corroborates this interpretation.
The psychological stress measures in this study were hardly
related to the physiological stress markers (i.e., maternal ANS
and amniotic fluid parameters). This is a phenomenon often
described in stress research (50,51). Interindividual differences
in stress appraisal and in the tendency to respond to question-
naires in a socially desirable manner might explain this lacking
association. An alternative explanation might involve the use of
the MMSQ in the present study as a measure to assess the
pregnant women’s acute psychological stress response to am-
niocentesis. The MMSQ measures general mood states. The
stress, fears, and worries of a pregnant woman regarding the
well-being of her unborn child in an amniocentesis situation
might not have been sufficiently captured this way thus, leading
to a lack of associations with physiological stress measures.
Future studies should take this factor into account. Also, ex-
cluding pregnant women with psychiatric diagnosis may have
limited the variance in psychological stress responses and simi-
larly contributed to this result.
Investigating the ANS during human pregnancy can further
our understanding of how maternal stress may reach the fetus
and initiate fetal programming effects. Evidence for an impor-
tant role of the ANS in fetal programming comes from studies
reporting a positive association between the blood pressure re-
sponse of healthy pregnant women and shorter gestational length
and low birthweight (52). Invarious epidemiological studies, low
birth weight has been identified as a predictor of cardiovascular
and metabolic disorders in adulthood even within the normal
birth weight range (cf. Ref. (9)). Furthermore, children’s systolic
blood pressure response at 3 years was predicted by the ratio
between E and F obtained from umbilical cord blood samples at
delivery (53). Thematernal ANS responses to stressmay regulate
the activity of the placental barrier enzyme 11A-HSD2. In vitro,
11A-HSD2 mRNA is down-regulated by NE and EPI (24),
leading to the assumption that chronic activation of the maternal
ANS due to stress mayweaken 11A-HSD2 activity and, as a result,
lead to fetal F excess. Results from the current study reporting a
negative association between LF and LF/HF baseline and amni-
otic E/(E + F) and simultaneously a positive association between
LF and LF/HF baseline and amniotic F parallel results of im-
paired 11A-HSD2 activity in chronically stressed pregnant
rats (12,13). Increased baseline levels of stressmarkers, including
LF/HF, have been found to reflect chronic stress exposure in
humans (54). However, our results still need to be viewed with
caution and confirmed in future studies. In addition, chronic ANS
activation may alter 11A-HSD2 activity by reduced placental ox-
ygen transfer. Reduced oxygen seems to impair 11A-HSD2 (14).
Correspondingly, prenatal anxiety (55) and psychological distress
(56) have been associated with impaired placental blood flow,
which, in turn results in reduced placental oxygen supplies (14).
The significant relationship between the acute LF/HF stress
response and amniotic E/(E + F) may indicate that higher
sympathovagal balance or, in other words, a greater shift to
sympathetic activation caused by stress, induces an up-regulation
of placental 11A-HSD2 activity in humans and corresponds to
findings in acute-stressed pregnant rats (12). Likewise, increased
LF/HF and also LF stress responses in our study were associated
with lower amniotic fluid F levels. This suggests that the acute
maternal stress response may activate allostatic processes in the
placenta, in agreement with the compensatory stress reactivity
model of McEwen (57), to shield the fetus from the detrimental
effects of F excess. Chronic stress, however, may weaken this
protective shield.
Although correlations between maternal LF, LF/HF, and
amniotic fluid F and E/(E + F) were found, thereby pointing
toward an involvement of the maternal ANS in the regulation of
fetoplacental 11A-HSD2 activity, it is improbable that these
ANS parameters are causally responsible for stress-induced
changes in 11A-HSD2. It is more likely that LF and LF/HF
mirror the activity of other ANS variables known to impair the
actions of the placental barrier enzyme, such as NE and EPI
(24) or placental oxygen transfer (14). However, future studies
need to investigate this hypothesis in more detail.
One of the main limitations of the current study is that we
did not measure placental 11A-HSD2 activity directly, which is
technically and ethically not possible during ongoing human
pregnancy. We measured amniotic fluid E/(E + F) as a marker of
11A-HSD2 in the fetoplacental unit. The ratio between F and E
obtained from umbilical venous cord blood after birth has been
found to correlate positively with placental 11A-HSD2 activity
(58). However, it remains unclear to what degree amniotic fluid
E/(E + F) at 15 to 17 weeks of gestation is a result of placental
or fetal 11A-HSD2 activity, but because the placenta has a
larger capacity of metabolizing F than the fetus (22), a large
fraction of the E/(E + F) ratio may reflect placental metabolism.
Obviously, it was also not possible to monitor the amniotic
fluid parameters as the maternal stress response unfolded over
time. Therefore, no clear statements can be made about the
effect of the maternal ANS response on the fetal stress re-
sponse. Moreover, although stress is capable of activating the
adult ANS within seconds, the time it takes for the maternal
ANS response to be measurable in the amniotic fluid is unclear.
In pregnant rabbits and guinea pigs, continuous infusion of NE
and EPI reduces placental blood flow causing fetal HR to de-
crease within 20 to 60 seconds after the infusion started (59).
Likewise in humans, fetal HR decreases within 1 minute after a
single injection of NE to the mother (60).
A further limitation concerns the rather advanced mean age
of 37 years in our sample of pregnant women, which possibly
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influenced the measurement of both psychological and physi-
ological markers to a certain degree. However, the mean age of
37 years is not unusual for pregnant women undergoing am-
niocentesis because the risk of chromosomal abnormalities
increases with advancing age. It also should be noted that the
average age of maternity in Switzerland has risen from 30.8
years in 2007 to 31.48 years in 2011 (30).
Whether and to what degree our results are influenced by the
activity of 11A-hydroxysteroid dehydrogenase type 1 (11A-
HSD1), which mainly catalyzes the opposite reaction as 11A-
HSD2, namely, the conversion of E to F, are unclear. 11A-HSD1
is present in the decidua, the chorion, and the endothelium of
the placental villous tissue and umbilical cord (61). However,
activity has not been detected in the fetal membranes between
16 to 19 weeks of gestation (22,62). Moreover, 11A-HSD2
activity strongly predominates 11A-HSD1 activity in the human
placenta (63).
The strengths of the study at hand include the examination
of the psychobiological stress response of different psycho-
logical and ANS parameters in pregnant women confronted
with a naturalistic stress situation and the comparison of these
with amniotic fluid F, E, and E/(E + F). The findings indicate
that the ANS and its potential association with 11A-HSD2 in
the fetoplacental unit is an important path for future research in
understanding how maternal prenatal stress may reach the fetus.
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